Bank of America’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
VPC
EP
VCM
YCM
IC
EAM
Bank of America's PASG Position: Q1 2026 in Review
Bank of America sold out of Passage Bio (PASG) in Q1 2026, closing a stake of 28 shares — an estimated $331 sold.
Bank of America first reported a position in PASG in Q1 2020 and held it in 21 quarters. The position peaked at $579K in Q4 2021. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.
- Bank of America reported no remaining Passage Bio position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 28 Passage Bio shares in Q1 2026, an estimated $331.
- Bank of America first reported a position in Passage Bio in Q1 2020 and held it in 21 quarters.
- Bank of America's Passage Bio position peaked at $579K in Q4 2021.
- 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.